ARCHIVES

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

This article is from The Cancer Letter archive.

Vol. 27 No. 45 | December 7, 2001

Download PDF Visit The Full Archive

Related Articles

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

Fluoride Study Update Finds No Increased Risk

October 19, 1990

NCI-Approved Trials Listed

April 28, 2006

In Brief: Lenhard Elected President Of ACS; House Science Committee Approves CRADA Bill

November 17, 1995

Cancer Advocates Use Benefit Analysis To Press For Funds

May 11, 1990